ExodusPoint Capital Management’s Antares Pharma, Inc. ATRS Stock Holding History

ExodusPoint Capital Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,479	Closed	-$43K	–	2754
2022 Q1	$43K	Buy	+10,479	New	+$38K	﹤0.01%	2073
2021 Q4	–	Sell	-41,888	Closed	-$152K	–	2787
2021 Q3	$152K	Sell	41,888 -4,955	-11%	-$20K	﹤0.01%	1835
2021 Q2	$204K	Sell	46,843 -244,233	-84%	-$995K	﹤0.01%	1971
2021 Q1	$1.2M	Buy	+291,076	New	+$1.26M	0.02%	812
2020 Q3	–	Sell	-85,430	Closed	-$235K	–	2386
2020 Q2	$235K	Buy	+85,430	New	+$238K	0.01%	1437
2020 Q1	–	Sell	-120,566	Closed	-$567K	–	1824
2019 Q4	$567K	Buy	+120,566	New	+$493K	0.01%	793

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ExodusPoint Capital Management's ATRS Position: Q2 2022 in Review

ExodusPoint Capital Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 10,479 shares — an estimated $43K sold.

ExodusPoint Capital Management first reported a position in ATRS in Q4 2019 and held it in 6 quarters. The position peaked at $1.2M in Q1 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

ExodusPoint Capital Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
ExodusPoint Capital Management sold 10,479 Antares Pharma, Inc. shares in Q2 2022, an estimated $43K.
ExodusPoint Capital Management first reported a position in Antares Pharma, Inc. in Q4 2019 and held it in 6 quarters.
ExodusPoint Capital Management's Antares Pharma, Inc. position peaked at $1.2M in Q1 2021.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.